- 24 women making moves in healthcare
- Investors renew fight against UnitedHealth, claiming $237M in insider stock sales
- Texas Health Resources CEO on forgoing M&A: ‘All those cases so far would be dilutive’
- What drives a US News Honor Roll hospital: 4 operational themes from 6 execs
- Luigi Mangione admits he shot UnitedHealthcare CEO
- Cleveland Clinic posts 5% operating margin in Q2: 5 things to know
- The ‘hidden tax’ squeezing hospital supply chains
- DermCare Management, US Dermatology Partners form national dermatology group
- HCA plans $300M Florida hospital
- 346 healthcare organizations named Forbes’ best-in-state employers
- The real reason ASC anesthesia departments struggle — and it’s not operations
- Single payer system would save $1 trillion, 114,000 lives annually: Yale study
- Nevada cuts psychiatric residential placements for children from 35% to 16%
- Seattle Children’s expands with $103M ASC
- 5 cardiologists in the headlines
- The toughest talks ASC leaders have with physicians
- Alabama developers to break ground on $35M ASC
- The specialties driving ASC growth through 2031
- Is the behavioral health access problem actually a quality problem?
- Nurses at SSM Health outpatient practices move to unionize
- 62% of ASCs cancel, delay cases over anesthesia gaps
- Processed Foods Linked To Prostate Cancer Risk
- Screen Time Is Not All Bad For Kids' Brains
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- Luigi Mangione pleads guilty in federal case over murder of UnitedHealthcare CEO Brian Thompson
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- Massachusetts moves to restrict kratom sales
- Meet the leaders of the fastest-growing dental practices
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Will cardiology’s ASC strategy pay off? CVL’s new CEO is betting on it
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Wisconsin woman accused of posing as fake dentist ordered to pay customer $144K
- Dentists battle insurance woes: 5 updates
- Philadelphia dentist dies at 86
- 4 injured after car crashes into North Carolina pediatric dental office
- Mental healthcare provider gaps, by state
- Park Dental Partners posts $66.2M in Q2 revenue
- 28 new behavioral health study findings to know
- 23 new behavioral health projects to know
- Aspen Dental continues 2026 growth with new Chicago practice
- Major PBMs agree to offer TrumpRx pricing information to members
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Nationwide program to quit smoking would save US $12B: Study
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- Angelalign to appeal court’s decision in clear aligner patent infringement case
- It's crunch time for Karyopharm as company faces potential default next month
- UNC Health Pardee completes 23-bed behavioral health center
- Oregon State Hospital superintendent out after less than a month
- Affordable Care completes recapitalization, enters ‘next chapter’ of growth
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers providers, PBMs to DOJ over youth gender care billing
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- CMS ends Medicaid, CHIP funding for gender-affirming care for minors
- Healthcare CFOs face growing decision-making expectations. Many say they aren't ready
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Claims data transparency empowers employers to act on affordability: survey
- Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Senators introduce bipartisan legislation to further antimicrobial resistance research
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
Michigan healthcare freedom community forum
The Democrats took control of the U.S. House in 2018 and the Government Accountability Office abruptly stopped disclosing their PPACA fraud investigation results. Now, 8 years later, the GAO is back investigating Obamacare for health care fraud. It is not a pretty picture:
https://www.gao.gov/products/gao-26-108742
Obamacare subsidies granted without documentation to 90% of fake accounts set up by government watchdog
By Victor Nava - December 3, 2025Affordable Care Act subsidies have been granted, without the required documentation, to 90% of fictitious applicants over the last two years, according to a damning government watchdog report released Wednesday.
The Government Accountability Office’s (GAO) preliminary findings of ongoing and covert testing of Obamacare found “fraud risks” in the federal ACA marketplace, specifically related to the healthcare program’s advance premium tax credit – a subsidy Democrats shut down the government over last month in a failed effort to extend the tax credit for three more years.
“The federal Marketplace approved coverage for nearly all of GAO’s fictitious applicants in plan years 2024 and 2025, generally consistent with similar GAO testing in plan years 2014 through 2016,” according to the government watchdog.
The GAO found evidence that fraudsters were using the same Social Security number to enroll in multiple ACA plans and extract more taxpayer-funded subsidies.
In plan year 2024, all four of GAO’s fake applicants received coverage with lower monthly premiums – thanks to $2,350 per month in Obamacare subsidies granted to insurers – despite not submitting “documentation to support Social Security numbers (SSN), citizenship, and reported income.”
The GAO upped the number of fake applicants to 20 in plan year 2025 and 18 still “remain actively covered as of September 2025.”
The subsidies that the 18 fake enrollees were approved for totaled “over $10,000 per month.”
Evidence of potential “misuse” of Social Security numbers, including dead people receiving coverage, was also discovered by the GAO.
In plan year 2023 alone, one Social Security number was used to receive subsidized insurance coverage “for over 26,000 days (over 71 years of coverage) across over 125 insurance policies.”
In 2024, 66,000 Social Security numbers were linked to more than a years’ worth of subsidized coverage.
GAO also compared Social Security numbers of the deceased to those that received tax credits and in 2023 and identified over 58,000 matches, including at least 7,000 people who died before coverage began.
The report explained that the Centers for Medicare and Medicaid Services, which oversees the federal marketplace for Obamacare, doesn’t bar a Social Security number already used for an enrollment to be used again – in order to allow people to get coverage in instances where identity theft takes place.
Top Republican lawmakers described the report as the “smoking gun” proving their claims that Obamacare is “broken.”
“GAO’s troubling report is the smoking gun that shows how this broken system, shielded by Democrat policies, has led to the federal government shoveling tens of billions of tax dollars to insurance companies through identity fraud and caused health care costs to skyrocket for all Americans,” House Ways and Means Committee Chairman Jason Smith (R-Mo.) said in a statement.
The GAO investigation was requested by Smith along with Energy and Commerce Committee Chairman Brett Guthrie (R-Ky.) and Judiciary Committee Chairman Jim Jordan (R-Ohio).
“Republicans have sounded the alarm on the flawed structural integrity of Obamacare and how Democrats’ failed policies to temporarily prop up the program have exacerbated fraud, hurt patients, increased the burden on American taxpayers, and artificially masked the true health care affordability crisis plaguing Americans today,” Guthrie said in a statement.
“The concerning findings from GAO’s report further confirm that Republican efforts to strengthen, secure, and sustain our federal health programs are critical and necessary to ensure access to quality health care at prices Americans can afford.”
Jordan said the report “confirms what we already knew: under Obamacare, hardworking Americans saw their premiums skyrocket and their healthcare choices shrink, all while fraud benefitted insurance companies.”
“Obamacare was built on lies and broken promises that hurt families and drove up costs,” the Ohio Republican added.
As part of deal Senate Democrats struck with Senate Majority John Thune (R-SD) last month to reopen the government, the upper chamber is expected to take up a vote on extending the pandemic-era ACA tax credit, which is currently set to expire at the end of the year.
The full GAO report runs 26 pages. Here are their very carefully worded highlights:
https://www.gao.gov/products/gao-26-108742
https://www.gao.gov/assets/gao-26-108742.pdf
Patient Protection and Affordable Care Act:
Preliminary Results from Ongoing Review Suggest Fraud Risks in the Advance Premium Tax Credit Persist
GAO-26-108742
Published: December 03, 2025. Publicly Released: December 03, 2025.Highlights
What GAO Found
Preliminary results from GAO's ongoing covert testing suggest fraud risks in the advance premium tax credit (APTC) persist. The federal Marketplace approved coverage for nearly all of GAO's fictitious applicants in plan years 2024 and 2025, generally consistent with similar GAO testing in plan years 2014 through 2016. GAO's covert testing is illustrative and cannot be generalized to the enrollee population.
- Plan year 2024. The federal Marketplace approved subsidized coverage for all four of GAO's fictitious applicants submitted in October 2024. In total, the Centers for Medicare & Medicaid Services (CMS) paid about $2,350 per month in APTC in November and December for these fictitious enrollees. For some, the federal Marketplace requested documentation to support Social Security numbers (SSN), citizenship, and reported income. GAO did not provide documentation yet received coverage.
- Plan year 2025. Of 20 fictitious applicants, 18 remain actively covered as of September 2025. APTC for these 18 enrollees totals over $10,000 per month. GAO continues to monitor the enrollments as part of its ongoing work.
More broadly, GAO's preliminary analyses identified vulnerabilities related to potential SSN misuse and likely unauthorized enrollment changes in federal Marketplace data for plan years 2023 and 2024. Such issues can contribute to APTC that is not reconciled through enrollees' tax filings to determine the amount of premium tax credit for which enrollees were ultimately eligible. GAO's preliminary analysis of data from tax year 2023 could not identify evidence of reconciliation for over $21 billion in APTC for enrollees who provided SSNs to the federal Marketplace for plan year 2023. Unreconciled APTC may not necessarily represent overpayments, as enrollees who did not reconcile may have been eligible for the subsidy. However, it may include overpayments for enrollees who were not eligible for APTC.
Overused SSNs. GAO's preliminary analyses identified over 29,000 SSNs in plan year 2023 and nearly 68,000 SSNs in plan year 2024 used to receive more than one year's worth of insurance coverage with APTC in a single plan year. CMS officials explained that the federal Marketplace does not prohibit multiple enrollments per SSN to help ensure that the actual SSN-holder can enroll in insurance coverage in cases of identity theft or data entry errors.
GAO's preliminary analyses also identified at least 30,000 applications in plan year 2023 and at least 160,000 applications in plan year 2024 that had likely unauthorized changes by agents or brokers. This can result in consumer harm, including loss of access to medications. In July 2024, CMS implemented a new control to prevent such changes, which GAO is reviewing in its ongoing work.GAO preliminarily identified weaknesses in CMS’s APTC fraud risk management as compared to leading practices. Specifically, CMS has not updated its fraud risk assessment since 2018 despite changes in the program and its controls. Further, CMS’s 2018 assessment may not fully align with leading practices, like identifying inherent fraud risks. Finally, CMS did not use its 2018 assessment to develop an antifraud strategy. Together, these weaknesses appear to hinder CMS’s ability to effectively and proactively manage fraud risks in APTC.
Why GAO Did This Study
The Patient Protection and Affordable Care Act provides premium tax credits to help eligible individuals pay for health insurance. The federal government can pay this credit directly to health insurance issuers as APTC. CMS estimated that it paid nearly $124 billion in APTC for about 19.5 million enrollees in plan year 2024. Consumers can enroll in insurance through the federal Marketplace independently or with assistance from an agent or broker.
Recent indictments highlight concerns about agent and broker practices in the federal Marketplace. Further, CMS reported that it received roughly 275,000 complaints in 2024 that consumers were enrolled or had insurance plans changed in the federal Marketplace without their consent.
GAO was asked to review issues related to fraud risk management in APTC. This report discusses preliminary results of ongoing GAO work related to (1) covert testing and (2) data analyses of enrollment controls in the federal Marketplace, as well as (3) CMS's APTC fraud risk assessment and antifraud strategy.
To perform this work, GAO created 20 fictitious identities and submitted applications for health care coverage in the federal Marketplace for plan years 2024 and 2025. The results, while illustrative, cannot be generalized to the full enrollment population. Additionally, GAO analyzed federal Marketplace enrollment data for plan years 2023 and 2024 and compared these data to federal death data and tax data. Finally, GAO assessed documentation related to CMS's fraud risk management activities against relevant leading practices.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























